Short duration radiotherapy in stage I seminoma of the testis: preliminary results of a prospective study.

2.50
Hdl Handle:
http://hdl.handle.net/10541/99800
Title:
Short duration radiotherapy in stage I seminoma of the testis: preliminary results of a prospective study.
Authors:
Read, G; Johnston, Ruth J
Abstract:
Ninety-four patients with Stage I seminoma of the testis, treated between November 1989 and December 1991, received short duration radiotherapy (2000 cGy in 8 fractions) to the para-aortic area only. The treatment was well tolerated and, after a median follow-up time of 34 months (minimum 15 months), no patient has relapsed in the abdomen. One patient developed an apparently solitary distant metastasis from a latent teratoma and is disease free after chemotherapy. This form of radiotherapy would appear to be well-tolerated with a low relapse rate. It offers the advantage of a simpler and shorter technique compared with conventional therapy and avoids the necessity of intensive surveillance to detect relapse.
Affiliation:
Department of Radiotherapy, Christie Hospital, Manchester, UK.
Citation:
Short duration radiotherapy in stage I seminoma of the testis: preliminary results of a prospective study. 1993, 5 (6):364-6 Clin Oncol (R Coll Radiol)
Journal:
Clinical Oncology
Issue Date:
1993
URI:
http://hdl.handle.net/10541/99800
DOI:
10.1016/S0936-6555(05)80087-1
PubMed ID:
8305356
Type:
Article
Language:
en
ISSN:
0936-6555
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorRead, Gen
dc.contributor.authorJohnston, Ruth Jen
dc.date.accessioned2010-05-25T11:38:57Z-
dc.date.available2010-05-25T11:38:57Z-
dc.date.issued1993-
dc.identifier.citationShort duration radiotherapy in stage I seminoma of the testis: preliminary results of a prospective study. 1993, 5 (6):364-6 Clin Oncol (R Coll Radiol)en
dc.identifier.issn0936-6555-
dc.identifier.pmid8305356-
dc.identifier.doi10.1016/S0936-6555(05)80087-1-
dc.identifier.urihttp://hdl.handle.net/10541/99800-
dc.description.abstractNinety-four patients with Stage I seminoma of the testis, treated between November 1989 and December 1991, received short duration radiotherapy (2000 cGy in 8 fractions) to the para-aortic area only. The treatment was well tolerated and, after a median follow-up time of 34 months (minimum 15 months), no patient has relapsed in the abdomen. One patient developed an apparently solitary distant metastasis from a latent teratoma and is disease free after chemotherapy. This form of radiotherapy would appear to be well-tolerated with a low relapse rate. It offers the advantage of a simpler and shorter technique compared with conventional therapy and avoids the necessity of intensive surveillance to detect relapse.en
dc.language.isoenen
dc.subjectCancer Stagingen
dc.subjectTesticular Canceren
dc.subject.meshAdult-
dc.subject.meshAged-
dc.subject.meshFollow-Up Studies-
dc.subject.meshHumans-
dc.subject.meshMale-
dc.subject.meshMiddle Aged-
dc.subject.meshNeoplasm Staging-
dc.subject.meshProspective Studies-
dc.subject.meshRadiotherapy Dosage-
dc.subject.meshSeminoma-
dc.subject.meshTesticular Neoplasms-
dc.subject.meshTreatment Outcome-
dc.titleShort duration radiotherapy in stage I seminoma of the testis: preliminary results of a prospective study.en
dc.typeArticleen
dc.contributor.departmentDepartment of Radiotherapy, Christie Hospital, Manchester, UK.en
dc.identifier.journalClinical Oncologyen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.